EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC-ND 4.0

Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer

Nobuaki Hoshino iD, Mitsuro Kanda, Koji Oba, Toru Aoyama, Michitaka Honda, Kosuke Kashiwabara, Hiromichi Maeda, Shuhei Mayanagi, Masaru Muto, Kenji Tanaka, Hisakazu Yamagishi, Junichi Sakamoto and 2 more

Colorectal Disease · 2025

DOI: 10.1111/codi.70317 ↗

At a glance

Journal article in Colorectal Disease, 2025. Written by Nobuaki Hoshino and 13 co-authors. Institution: Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. Major MEDLINE topics: Colorectal Neoplasms, Fluorouracil, Antimetabolites, Antineoplastic. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Japanese Foundation for Multidisciplinary Treatment of Cancer.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Adjuvant chemotherapy after radical resection is recommended for patients with high‐risk Stages II and III colorectal cancer (CRC). However, the efficacy and safety of adjuvant chemotherapy in geriatric patients require elucidation.

Methods

We analysed data from seven clinical trials conducted by the Japanese Foundation for the Multidisciplinary Treatment of Cancer. Survival curves were estimated using the Kaplan–Meier method and compared using the log‐rank test. Survival analysis was performed using a Cox proportional hazards model.

Results

This study included 7756 non‐geriatric (

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsFluorouracilAntimetabolites, AntineoplasticHumansAgedChemotherapy, AdjuvantFemaleMaleJapanAged, 80 and overProportional Hazards ModelsMiddle AgedTreatment OutcomeKaplan-Meier EstimateClinical Trials as TopicAge FactorsAdministration, OralSurvival RateSurvival AnalysisEast Asian People

Author keywords

adjuvant chemotherapycolorectal neoplasmsgeriatricmeta‐analysis

Substances

FluorouracilAntimetabolites, Antineoplastic

Authors and institutions

  • Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.
  • Data Science Office, Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.

ORCID profiles: Nobuaki Hoshino

Funding

  • The Japanese Foundation for Multidisciplinary Treatment of Cancer

Cite

APA

Hoshino, N., Kanda, M., Oba, K., Aoyama, T., Honda, M., Kashiwabara, K., Maeda, H., Mayanagi, S., Muto, M., Tanaka, K., Yamagishi, H., Sakamoto, J., Obama, K., & Yoshikawa, T. (2025). Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer. Colorectal Disease. https://doi.org/10.1111/codi.70317

Vancouver

Hoshino N, Kanda M, Oba K, Aoyama T, Honda M, Kashiwabara K, et al. Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer. Colorectal Disease. 2025. doi:10.1111/codi.70317

BibTeX
@article{Hoshino2025,
  author = {Hoshino, Nobuaki and Kanda, Mitsuro and Oba, Koji and Aoyama, Toru and Honda, Michitaka and Kashiwabara, Kosuke and Maeda, Hiromichi and Mayanagi, Shuhei and Muto, Masaru and Tanaka, Kenji and Yamagishi, Hisakazu and Sakamoto, Junichi and Obama, Kazutaka and Yoshikawa, Takaki},
  title = {Efficacy and safety of oral 5‐ FU ‐based adjuvant chemotherapy for geriatric patients with colorectal cancer: Integrated analysis of seven clinical trials conducted at the Japanese Foundation for Multidisciplinary Treatment of Cancer},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70317}
}
Start for free →